BLRX Annual Total Long Term Liabilities
$19.85 M
+$4.99 M+33.54%
31 December 2023
Summary:
As of January 23, 2025, BLRX annual total long term liabilities is $19.85 million, with the most recent change of +$4.99 million (+33.54%) on December 31, 2023. During the last 3 years, it has risen by +$5.23 million (+35.78%). BLRX annual total long term liabilities is now at all-time high.BLRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLRX Quarterly Long Term Liabilities
$19.27 M
-$824.00 K-4.10%
01 September 2024
Summary:
As of January 23, 2025, BLRX quarterly total long term liabilities is $19.27 million, with the most recent change of -$824.00 thousand (-4.10%) on September 1, 2024. Over the past year, it has dropped by -$5.72 million (-22.89%). BLRX quarterly long term liabilities is now -24.22% below its all-time high of $25.44 million, reached on June 30, 2023.BLRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLRX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.5% | -22.9% |
| 3 y3 years | +35.8% | +238.7% |
| 5 y5 years | +143.2% | +238.7% |
BLRX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +453.7% | -24.2% | +1076.7% |
| 5 y | 5-year | at high | +453.7% | -24.2% | +1076.7% |
| alltime | all time | at high | >+9999.0% | -24.2% | >+9999.0% |
BioLineRx Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.27 M(-4.1%) |
| June 2024 | - | $20.10 M(+180.4%) |
| Mar 2024 | - | $7.17 M(-63.9%) |
| Dec 2023 | $19.85 M(+33.5%) | $19.85 M(-20.6%) |
| Sept 2023 | - | $25.00 M(-1.7%) |
| June 2023 | - | $25.44 M(+45.4%) |
| Mar 2023 | - | $17.49 M(+17.7%) |
| Dec 2022 | $14.86 M(+314.6%) | $14.86 M(-17.5%) |
| Sept 2022 | - | $18.02 M(+999.9%) |
| June 2022 | - | $1.64 M(-27.6%) |
| Mar 2022 | - | $2.26 M(-36.9%) |
| Dec 2021 | $3.58 M(-75.5%) | $3.58 M(-37.0%) |
| Sept 2021 | - | $5.69 M(-24.3%) |
| June 2021 | - | $7.52 M(-13.9%) |
| Mar 2021 | - | $8.74 M(-40.2%) |
| Dec 2020 | $14.62 M(+77.9%) | $14.62 M(+35.9%) |
| Sept 2020 | - | $10.76 M(-10.6%) |
| June 2020 | - | $12.04 M(+74.5%) |
| Mar 2020 | - | $6.90 M(-16.1%) |
| Dec 2019 | $8.22 M(+0.7%) | $8.22 M(+3.6%) |
| Sept 2019 | - | $7.94 M(-31.7%) |
| June 2019 | - | $11.62 M(-14.4%) |
| Mar 2019 | - | $13.57 M(+66.3%) |
| Dec 2018 | $8.16 M(+499.2%) | $8.16 M(+817.0%) |
| Sept 2018 | - | $890.00 K(+29.2%) |
| June 2018 | - | $689.00 K(-21.1%) |
| Mar 2018 | - | $873.00 K(-35.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $1.36 M(+442.6%) | $1.36 M(-13.6%) |
| Sept 2017 | - | $1.58 M(+672.5%) |
| June 2017 | - | $204.00 K(-10.5%) |
| Mar 2017 | - | $228.00 K(-9.2%) |
| Dec 2016 | $251.00 K(-54.5%) | $251.00 K(-16.6%) |
| Sept 2016 | - | $301.00 K(-3.2%) |
| June 2016 | - | $311.00 K(-18.2%) |
| Mar 2016 | - | $380.00 K(-31.2%) |
| Dec 2015 | $552.00 K(-63.2%) | $552.00 K(-28.3%) |
| Sept 2015 | - | $770.00 K(-67.7%) |
| June 2015 | - | $2.39 M(+55.0%) |
| Mar 2015 | - | $1.54 M(+2.7%) |
| Dec 2014 | $1.50 M(-71.4%) | $1.50 M(+1.5%) |
| Sept 2014 | - | $1.48 M(-50.6%) |
| June 2014 | - | $3.00 M(-15.8%) |
| Mar 2014 | - | $3.56 M(-32.1%) |
| Dec 2013 | $5.24 M(+80.1%) | $5.24 M(+40.5%) |
| Sept 2013 | - | $3.73 M(+51.2%) |
| June 2013 | - | $2.47 M(-16.3%) |
| Mar 2013 | - | $2.95 M(+1.3%) |
| Dec 2012 | $2.91 M(+5637.7%) | $2.91 M(-8.7%) |
| Sept 2012 | - | $3.18 M(+9.9%) |
| June 2012 | - | $2.90 M(-23.5%) |
| Mar 2012 | - | $3.79 M(+7374.8%) |
| Dec 2011 | $50.70 K | $50.70 K(-14.1%) |
| Sept 2011 | - | $59.00 K(-33.1%) |
| June 2011 | - | $88.20 K(-19.2%) |
| Mar 2011 | - | $109.10 K |
FAQ
- What is BioLineRx annual total long term liabilities?
- What is the all time high annual total long term liabilities for BioLineRx?
- What is BioLineRx annual total long term liabilities year-on-year change?
- What is BioLineRx quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for BioLineRx?
- What is BioLineRx quarterly long term liabilities year-on-year change?
What is BioLineRx annual total long term liabilities?
The current annual total long term liabilities of BLRX is $19.85 M
What is the all time high annual total long term liabilities for BioLineRx?
BioLineRx all-time high annual total long term liabilities is $19.85 M
What is BioLineRx annual total long term liabilities year-on-year change?
Over the past year, BLRX annual total long term liabilities has changed by +$4.99 M (+33.54%)
What is BioLineRx quarterly total long term liabilities?
The current quarterly long term liabilities of BLRX is $19.27 M
What is the all time high quarterly long term liabilities for BioLineRx?
BioLineRx all-time high quarterly total long term liabilities is $25.44 M
What is BioLineRx quarterly long term liabilities year-on-year change?
Over the past year, BLRX quarterly total long term liabilities has changed by -$5.72 M (-22.89%)